Cargando…
SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715624/ https://www.ncbi.nlm.nih.gov/pubmed/34974378 http://dx.doi.org/10.1016/j.clineuro.2021.107106 |
| _version_ | 1784624164282302464 |
|---|---|
| author | Scorza, Fulvio A Finsterer, Josef |
| author_facet | Scorza, Fulvio A Finsterer, Josef |
| author_sort | Scorza, Fulvio A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8715624 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87156242021-12-29 SARS-CoV-2 vaccination triggered Guillain-Barre syndrome Scorza, Fulvio A Finsterer, Josef Clin Neurol Neurosurg Correspondence Elsevier B.V. 2022-02 2021-12-29 /pmc/articles/PMC8715624/ /pubmed/34974378 http://dx.doi.org/10.1016/j.clineuro.2021.107106 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Scorza, Fulvio A Finsterer, Josef SARS-CoV-2 vaccination triggered Guillain-Barre syndrome |
| title | SARS-CoV-2 vaccination triggered Guillain-Barre syndrome |
| title_full | SARS-CoV-2 vaccination triggered Guillain-Barre syndrome |
| title_fullStr | SARS-CoV-2 vaccination triggered Guillain-Barre syndrome |
| title_full_unstemmed | SARS-CoV-2 vaccination triggered Guillain-Barre syndrome |
| title_short | SARS-CoV-2 vaccination triggered Guillain-Barre syndrome |
| title_sort | sars-cov-2 vaccination triggered guillain-barre syndrome |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715624/ https://www.ncbi.nlm.nih.gov/pubmed/34974378 http://dx.doi.org/10.1016/j.clineuro.2021.107106 |
| work_keys_str_mv | AT scorzafulvioa sarscov2vaccinationtriggeredguillainbarresyndrome AT finstererjosef sarscov2vaccinationtriggeredguillainbarresyndrome |